1 / 19

Six-Year Outcomes After Sirolimus-eluting Stent Implantation SIRIUS Study

. Background. In the SIRIUS trial, the Sirolimus-eluting Bx VELOCITY Stent (SES) showed significant benefit compared to the bare-metal Bx VELOCITY Stent control in short-term safety and efficacy, and this significant improvement has been sustained for all clinical endpoints (TLR, TVR, TVF, and MAC

gannon
Télécharger la présentation

Six-Year Outcomes After Sirolimus-eluting Stent Implantation SIRIUS Study

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

    1. Six-Year Outcomes After Sirolimus-eluting Stent Implantation (SIRIUS Study) Martin B. Leon, David R. Holmes, Dean J. Kereiakes, Jeffrey J. Popma, Paul S. Teirstein, Jeffrey W. Moses, Huong P. Wang, Sidney A. Cohen, Donald E. Cutlip, for the SIRIUS Investigators CRT 2009

More Related